Reports
Drug Science and our collaborators regularly publish detailed reports which scrutinize current drug policies and suggest evidence-based improvements
Summary Full Report Survey Data Does the UK support psilocybin research?Public perceptions of psilocybin-assisted therapy have been revealed in a new YouGov poll, commissioned by Drug Science. This is the first nationally representative poll of UK attitudes towards the medicalisation of psilocybin and support for policy changes (such as rescheduling psilocybin)…
- June 3, 2021
Call for Evidence – Part Two focused on prevention, treatment and recovery. Drug Science has submitted its findings to Dame Carol Black to be considered in Part 2 of her independent review of drugs. The full submission can be found here: [vc_btn title="Drug Science Submission" style="custom" custom_background="#ff6259" custom_text="#ffffff" align="center" button_block="true"…
- September 3, 2020
The Royal College of Psychiatrists has undertaken a review to develop a College position on cannabis use in the UK and how this relates to mental health, incorporating evidence on the biological, psychological and social effects of cannabis, and the use of medicinal cannabis in relation to mental illness. The review…
- June 19, 2019
The UK Government Health and Social Committee invited submissions to review the current policy positions in the UK. Read Drug Science's written submission here, and watch the oral submissions given by several other leading UK drug policy and health organisations: Health and harms: What is the extent of health harms resulting…
- May 14, 2019
On 11 September 2018, the ACMD published its Advice to the Home Secretary and to the Secretary of State for Health and Social Care. It is a constructive document that highlights a number of issues and problems that this commentator has raised for some time. In some respects the document is…
- September 11, 2018
The Liberal Democrats became the first UK political party to call for cannabis legalisation. An expert report was commissioned by the Lib Dems to outline a framework for a regulated market. Three DrugScience members sat on the panel - Steve Rolles, Prof. Fiona Measham and Prof. David Nutt. Read the report…
- April 3, 2016